loader2
Partner With Us NRI

Camlin Fine Sciences Ltd share Price Today

Company details

106.69
109.99
79.95
186.35
6M Return -18.47%
1Y Return -35.08%
Mkt Cap.(Cr) 1,798.07
Volume 632,033
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 632,033

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Specialty Chemicals firm Camlin Fine Sciences announced Q1FY23 Result : 

  • Q1FY23 Revenues constant despite shutdown of Diphenol Plant at Dahej for 4 weeks.
  • Robust growth in Blends business continues
  • Increase in Operational EBITDA despite higher energy cost in CFS Europe continuing in current quarter
  • Energy cost in subsidiary CFS Europe SpA, Italy remained at high level due to Russia-Ukraine conflict. For Q1 FY 23, the said costs were higher by Rs. 47.8 mn as compared to Q4 FY22 and Rs. 255.8 mn as compared to Q1 FY22.
  • The impact has been recovered to some extent by increase in selling prices during Q1 FY23 and Q4 FY22.
  • Capital expansion plan of Methyl / Ethyl Vanillin is in final stage, commercial production expected in near future
  • Debottlenecking of Diphenol Plant completed in May'22, capacity enhanced to 15,000 MT from 10,000 MT

 

Result PDF

View Other Company Results

Camlin Fine Sciences Ltd shares SWOT Analysis

Strengths (3)

  • Company reducing Debt
  • Book Value per share Improving for last 2 years
  • FII / FPI or Institutions increasing their shareholding

Weakness (10)

  • Promoters increased pledged shares QoQ
  • Red Flag: High Interest Payments Compared to Earnings
  • Inefficient use of shareholder funds - ROE declining in the last 2 years

Opportunity (2)

  • Stock with Low PE (PE < = 10)
  • RSI indicating price strength

Threats (1)

  • Increasing Trend in Non-Core Income

Resistance and support

R1 109.3
R2 111.3
R3 112.6
Pivot

108.02

S1 106.0
S2 104.7
S3 102.7
EMA SMA
103.8
103.5
109.4
120.6
101.0
102.5
108.0
126.3
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
ANFIMA NV Bulk Purchase 2024-04-05 97.99 2300000 BSE
ASHISH SUBHASH DANDEKAR Bulk Sell 2024-04-05 97.99 2300000 BSE
ANFIMA NV Block Purchase 2024-04-05 97.99 2300000 BSE
Name Category Shares
Ashish Subhash Dandekar PROMOTER 11.73%
Subhash Digambar Dandekar PROMOTER 0.61%
Infinity Holdings PROMOTER 6.37%
Infinity Direct Holdings PROMOTER 12.35%
Anfima Nv PROMOTER 6.62%
Infinity Direct Holdings Sidecar I PROMOTER 3.31%
Camart Finance Limited PROMOTER 3.18%
Vibha Agencies Pvt Ltd PROMOTER 1.56%
Cafco Consultants Limited PROMOTER 0.89%
Anagha Subhash Dandekar PROMOTER 1.37%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Camlin Fine Sciences Ltd Stocks COMPARISON

Financials( in Cr) Camlin Fine Sciences Ltd Pidilite Industries Ltd SRF Ltd Linde India Ltd Gujarat Fluorochemicals Ltd
Price 107.37 3,107.10 2,420.25 8,304.25 3,305.20
% Change -0.89 -1.19 -1.62 -0.69 -2.14
Mcap Cr 1,798.07 158,029.90 71,742.26 70,821.97 36,307.62
Revenue TTM Cr 1,681.56 11,799.10 13,138.52 3,135.52 5,684.66
Net Profit TTM Cr 39.81 1,288.87 1,335.71 538.06 1,323.05
PE TTM 0.00 88.70 53.85 163.14 83.65
1 Year Return -35.08 16.32 1.27 81.21 5.81
ROCE 10.65 24.24 12.52 16.29 29.38
ROE 6.28 18.93 12.25 14.70 27.07
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 816.07 Cr FV: 1.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 34,603.75 11,365.18
LAST 3M 103,254.09 -13,985.70
LAST 6M 182,650.74 -3,739.19
LAST 12M 295,819.56 101,589.49

Camlin Fine Sciences Ltd Information

Stock PE (TTM)
0
Promoter Holding
48.03%
Book Value
47.8252
ROCE
10.65%
ROE
6.28%
Description
  • Camlin Fine Chemicals Ltd is one of the India`s leading manufacturers and exporters of Bulk Drugs, Fine Chemicals and Food Grade products. The company manufactures active pharmaceutical ingredients (API`s), food antioxidants and sweeteners. They operate in two business divisions, namely Food Ingredients Division and Industrial products Division. The company`s products have applications in processed foods, edible oils, paints, polymers, alternative fuels (biodiesel), rubber, health, and pharmaceuticals. The company has a strong research and development which is focused on bringing in continual improvements on process and products, backward integration and developing innovative products. The research and development is equipped with comprehensive and updated instrumentation for conducting quality analysis, stability studies. The research and development also is equipped to conduct application studies on stability index of edible oils and Bio-diesel. Camlin Fine Chemicals Ltd was originally incorporated on November 30, 1993 as a private limited company with the name of Camlicon Consultants Pvt Ltd. In April 2006, the main object of the company was altered to enable the company to pursue business in Fine Chemicals. They launched a new product namely, "Sucralose" which is a synthetic sweetener with large demand and attractive price. In June 1, 2006, the name of the company was changed from Camlicon Consultants Pvt Ltd to Camlin Fine Chemicals Pvt Ltd. As per the scheme of arrangement, the fine chemicals division of Camlin Ltd was de-merged and transferred to the company with effect from July 01, 2006. In August 11, 2006, the company was converted into public limited company and the name was changed to Camlin Fine Chemicals Pvt Ltd. The company entered into a joint venture with Viachem LLC USA on 51:49 basis and set up a company namely, Dulcette Technologies LLC for marketing Sucralose, Aspartame and Acesulfame-K and their blends in USA, Canada and Mexico. In March 30, 2007, the equity shares of the company were listed on the Bombay Stock Exchange (BSE). During the year 2007-08, the company increased the production capacity of Chemical & Chemical Products from 1,636 Ltrs/Kgs to 2,476 Ltrs/Kgs. The company acquired the control of Sangam Laboratories Ltd by acquiring 60% of the paid up equity share capital of the company. They invested Rs 5 lakh for controlling interest in the Equity Share Capital of Chemolutions Chemicals Ltd. In February 2008, the company entered into a joint venture agreement with Advanced Aerospace Technologies Inc., USA" to manufacture and market speciality fine chemicals primarily to cater to European and U.S markets. During the year 2008-09, the company expanded the production capacity of Chemical & Chemical Products from 2,476 Ltrs/Kgs to 2,548 Ltrs/Kgs. The company invested Rs 25.50 lakh in Fine Lifestyle Brands Ltd and Rs.5.10 lakh in Fine Renewable Energy Ltd, which represents 51% of equity share capital of each of them. They further invested Rs 92.32 lakh in the share capital of their present subsidiaries, namely Sangam Laboratories Ltd, Chemolutions Chemicals Ltd and Dulcette Technologies LLC, USA. During the year 2009-10, the company expanded the production capacity of Chemical & Chemical Products from 2,458 Ltrs/Kgs to 3,500 Ltrs/Kgs. They are entering the field of Bio technology products and first patented, biotechnology based Natural shelf life enhancing formula for increasing shelf life of Natural farm produce, like fruits, vegetables and flowers. During the year 2011, Chemolutions Chemicals Limited, Fine Lifestyle Brands Limited and Fine Renewable Energy Limited ceased to be subsidiaries of the Company. The Hon`ble High Court Bombay, vide order dated 21st April, 2011 approved Scheme of Amalgamation for merger of Sangam Laboratories Limited, a 100% owned subsidiary with the Company. W.e.f. 27th August, 2011 name of the Company was changed from Camlin Fine Chemicals Limited to Camlin Fine Sciences Limited. The establishment of two major business divisions, namely, Food and Industrial Products was completed. The Company expanded its manufacturing capacity of the food antioxidants, Ascorbyl Palmitate, TBHQ and BHA in 2012-13. In January 2016, it started operations in Central America with the launch of CFS Antioxidantes De Mexico, S.A. de C.V., a 100% subsidiary of Camlin Fine Sciences Ltd., acquired 65% stake in Dresen Qu�mica S.A.P.I de C.V, a leading food and feed blend company in Mexico; launched CFS North America, LLC, a 100% owned subsidiary of CFS for manufacturing and selling of customised antioxidant blends; launched Evanil, ethyl vanillin for food and bakery industry. On 15th April, 2016, a 100% wholly owned subsidiary CFS International Trading (Shanghai) Ltd. was incorporated in China (Shanghai) pilot free trade zone to manufacture and deal in speciality chemicals. On 22nd March, 2017, Chemolutions Chemicals Limited (CCL) allotted 62,67,003 equity shares on preferential basis to the Company. Post allotment, the shareholding of Company in CCL was 94.08% and CCL became the subsidiary of the Company. In July 2017, Company through its wholly owned stepdown subsidiary viz. CFS Europe S.p.A. acquired 51% stake in CFS Wanglong Flavours (Ningbo) Co. Ltd. erstwhile Ningbo Wanglong Flavors and Fragrances Company Limited. In April 2018, Company signed a joint venture contract with Pahang Pharma (S) Pte. Ltd., Singapore (Pahang) for incorporating a holding company, shareholding in the proportion of 51:49, named CFS Pahang Asia Pte. Ltd. in Singapore. In 2019, the Company reverse merged its wholly owned subsidiary in Mauritius viz., CFCL Mauritius Private Limited into CFS Europe Spa, Italy effective 25th June, 2019 and resultant to this merger, CFS Europe Spa became a wholly-owned subsidiary. The reverse merger of CFS Antioxidnates De Mexico De CV with Dresen Quimica SAPI De CV was effective 31st January, 2019 and resultant to reverse merger, CFS Antioxidantes De Mexico S.A. de. C.V. ceased to be the wholly-owned subsidiary of the Company from the aforementioned date. As a part of this initiative, Company acquired a company situated in Southern part of India, namely, AlgalR Nutrapharms Private Limited (AlgalR) which manufactures oils containing Omega 3 Fatty Acids. The company embarked upon its largest greenfield expansion in 2018 in Dahej, Gujarat for a green-technology-based DiPhenol plant for a 10,000 MT Di-Phenol facility. And in September 2020, it announced the commercial production of Hydroquinone and Catechol. During the financial year 2021-22, AlgalR NutraPharms Private Limited and CFS De Mexico Blends SAPI De CV became subsidiaries and Fine Lifestyle Brands Limited has ceased to be a Associate of the Company.

Registered Address

Plot No F/11 & F/12 WICEL, Central Road Andheri(East), Mumbai, Maharashtra, 400093

Tel : 91-22-67001000
Email : secretarial:camlinfs.com; corporate:camlinks.com
Website : http://www.camlinfs.com
Registrar

Sharepro Services India P Ltd

AGM Date (Month) : Jul
Face Value Equity Shares : 1
Market Lot Equity Shares : 1
BSE Code : 532834
NSE Code : CAMLINFINE
Book Closure Date (Month) : Jul
BSE Group : A
ISIN : INE052I01032

FAQ’s on Camlin Fine Sciences Ltd Shares

You can buy Camlin Fine Sciences Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Camlin Fine Sciences Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 24, 2024 03:58 PM the closing price of Camlin Fine Sciences Ltd was Rs.107.37.

The latest PE ratio of Camlin Fine Sciences Ltd as of Jun 24, 2024 03:58 PM is 0.00

The latest PB ratio of Camlin Fine Sciences Ltd as of Jun 24, 2024 03:58 PM is 0.45

The 52-week high of Camlin Fine Sciences Ltd share price is Rs. 186.35 while the 52-week low is Rs. 79.95

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 24, 2024 03:58 PM, the market cap of Camlin Fine Sciences Ltd stood at Rs. 1,798.07 Cr.

Download App

Download Our App

Play Store App Store
market app